title: Real-world experience with posaconazole prophylaxis in high-risk hematological patients in Singapore: a prospective audit.
authors.forename: Chian Yong
authors.initials: CY
authors.lastname: Low
authors.forename: Wen Chong
authors.initials: WC
authors.lastname: Ong
authors.forename: Evelyn
authors.initials: E
authors.lastname: Wong
authors.forename: Ying
authors.initials: Y
authors.lastname: Ding
authors.forename: Colin Phipps
authors.initials: CP
authors.lastname: Diong
authors.forename: Jing
authors.initials: J
authors.lastname: Jin
authors.forename: Zi Yi
authors.initials: ZY
authors.lastname: Lim
authors.forename: Li Yang
authors.initials: LY
authors.lastname: Hsu
mesh_terms: D000284:Administration, Oral; D000328:Adult; D000935:Antifungal Agents / Q000008:administration & dosage* / Q000009:adverse effects; D006402:Hematologic Diseases / Q000628:therapy*; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D016867:Immunocompromised Host; D008485:Medical Audit; D008875:Middle Aged; D009181:Mycoses / Q000517:prevention & control*; D011446:Prospective Studies; D012846:Singapore; D016896:Treatment Outcome; D014230:Triazoles / Q000008:administration & dosage* / Q000009:adverse effects
chemical_list: D000935:Antifungal Agents; D014230:Triazoles; C101425:posaconazole